Affiliations: Department of Neurosurgery, Georgetown University Hospital, Washington, DC, USA | Medstar Washington Hospital Center, Washington, DC, USA | Georgetown University School of Medicine, Arlington, VA, USA | Division of Neurosurgery, Children’s National Medical Center, Washington, DC, USA
Note: [] Corresponding author: Suresh N. Magge, Division of Neurosurgery Children’s National Medical Center, Assistant Professor of Neurosurgery and Pediatrics, George Washington University Medical Center, 111 Michigan Avenue NW, 4th Floor West Wing, Suite 100, Washington, DC 20010, USA. Tel.: +1 202 476 5000; Fax: +1 202 476 3091; E-mail: [email protected].
Abstract: Cerebral ischemia is a well-recognized cause of morbidity in the pediatric population. Moyamoya disease, first described in 1957 by Takeuchi and Shimizu, is an idiopathic chronic vasculopathy that often presents with ischemia. Moyamoya syndrome presents with similar clinical manifestations and disease progression but may occur unilaterally or in the setting of a predisposing condition. Both direct and indirect revascularization procedures have proven to be efficacious for pediatric moyamoya patients.
